Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and Obesity

1,2-distearoylphosphatidylethanolamine has been researched along with Obesity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akita, H; Harashima, H; Hossen, MN; Hyodo, M; Kajimoto, K1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Obesity

ArticleYear
Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.
    Journal of controlled release : official journal of the Controlled Release Society, 2012, Oct-28, Volume: 163, Issue:2

    Topics: Adipose Tissue; Animals; Azoles; Cholesterol; Diet, High-Fat; Drug Carriers; Endothelial Cells; Fluorescent Dyes; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Nitrobenzenes; Obesity; Oligopeptides; Phosphatidylcholines; Phosphatidylethanolamines; Prohibitins; Repressor Proteins

2012